Loading...
Images of Helga Gerets
(0 from 0 )Network Profiles
LinkedIn: Helga Gerets | LinkedIn
Helga Gerets’ berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Helga Gerets dabei hilft ...
LinkedIn: Helga Gerets | LinkedIn
View Helga Gerets’ professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Helga Gerets …
Business Profiles
Researchgate: Helga Gerets
Brussels, Belgium
Books & Literature
Analysis of HSP90 using a toxicity-based triaging approach for drug ...zh.booksc.eu › book
zh.booksc.eu
... development Jean-Pierre Valentin, Franck Atienzar, Reiner Class, Annie Delaunois, Renaud Fleurance, Helga Gerets, Stéphanie Glineur, Vitalina Gryshkova, ...
Related Documents
CiteSeerX — Determination of phospholipidosis potential based on gene...
citeseerx.ist.psu.edu
@ARTICLE{Atienzar_determinationof, author = {Franck Atienzar and Helga Gerets and Simon Dufrane and Karen Tilmant and A Cornet and Stephane Dhalluin and Bernard Ruty and Geoffrey Rose and Michael Canning}, title = {Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells}, journal
Helga Gerets Senior Scientist, In Vitro...
www.smi-online.co.uk
Helga Gerets Senior Scientist, In Vitro Toxicology UCB Dr. Helga Gerets is a Molecular Toxicologist at UCB Pharma in Braine-l’Alleud, Belgium.
CiteSeerX — Evaluation of Impedance-Based Label-Free Technology as a...
citeseerx.ist.psu.edu
BibTeX @MISC{Andréatienzar13evaluationof, author = {Franck Andréatienzar and Helga Gerets and Karen Tilmant and Gaëlle Toussaint and Stéphane Dhalluin}, title
Determination of Phospholipidosis Potential Based on Gene Expression...
academic.oup.com
Helga Gerets,. Helga Gerets. UCB Pharma SA, Non-Clinical Development, Chemin du Foriest, Braine-l'Alleud, Belgium. Search for other works by this ...
Scientific Publications
Principles and procedures for handling out-of-domain and...
www.sciencedirect.com
Author links open overlay panel Alexander Amberg a Roxanne V. Andaya b Lennart T. Anger a Chris Barber c Lisa Beilke d Joel Bercu e Dave Bower f Alessandro Brigo g Zoryanna Cammerer h Kevin P. Cross f Laura Custer i Krista Dobo j Helga Gerets k Véronique Gervais l Susanne Glowienke m Stephen Gomez n Jacky Van Gompel o James Harvey p …
Philip Hewitt - Scientist | Merck KGaA, Darmstadt, Germanywww.emdgroup.com › Research › Science Space › Scientist Profiles
www.emdgroup.com
Rowena Sison-Young, Volker M. Lauschke, Esther Johann, Eliane Alexandre, Sebastien Antherieu, Hélène Aerts, Helga Gerets, Gilles Labbe, Christopher ...
Publications
Evaluation of Impedance-Based Label-Free Technology as a Tool for...
core.ac.uk
Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations . By Franck Andréatienzar, Helga Gerets, Karen Tilmant, Gaëlle Toussaint and Stéphane Dhalluin. Abstract. biosensor Topics: real-time cell analyzer (RT ...
MDPI | Article Reprints Order
www.mdpi.com
MDPI is a publisher of peer-reviewed, open access journals since its establishment in
Biosensors - oalibwww.oalib.com › journal
www.oalib.com
Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations · Franck André Atienzar,Helga Gerets,Karen ...
Reports & Statements
CrossRef Cited By Search Results : nature.com
www.nature.com
Nature - the world's best science and medicine on your desktop
Miscellaneous
Volume 96 Issue 1 | Toxicological Sciences | Oxford Academic
academic-oup-com.eres.qnl.qa
Franck Atienzar, Helga Gerets, Simon Dufrane, Karen Tilmant, Miranda Cornet ... Toxicological Sciences, Volume 96, Issue 1, March 2007, Pages 101–114, ...
Scilit | Article - Investigative safety strategies to improve success...
www.scilit.net
Understanding and reducing attrition rate remains a key challenge in drug development. Preclinical and clinical safety issues still represent about 40% of drug...
ISS-1a :: EUROTOX 2017, Bratislava, Slovak Republic
www.eurotox2017.com
ISS_1a-04 De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development Jean-Pierre Valentin, Franck Atienzar, Reiner Class, Annie Delaunois, Renaud Fleurance, Helga Gerets, Stéphanie Glineur, Vitalina Gryshkova, Peter Hall, Catrin Hasselgren, Karen Tilmant
Journal | Journal of Medicines Development Sciences
www.scilit.net
Scilit is a centralized platform for all published research literature, articles with a DOI or in PubMed are indexed within hours
Biosensors - ISSN:
journaldatabase.info
Academic Journals Database is a universal index of periodical literature covering basic research from all fields of knowledge, and is particularly strong in...
Vol 2. No. 1 (Published) - ojs.whioce.com
ojs.whioce.com
by Franck Atienzar, Annie Delaunois, Frédéric Brouta, Miranda Cornet, Renaud Fleurance, Helga Gerets, Stéphanie Glineur, Catrin Hasselgren, Andrea Kiessling, Andre Nogueira da Costa, Marie-Luce Rosseels, Karen Tilmant, Jean-Pierre Valentin
Open Journal Systems - Journals - Whioce Publishingojs.whioce.com › index.php › jmds › article › view
ojs.whioce.com
Franck Atienzar, Annie Delaunois, Frédéric Brouta, Miranda Cornet, Renaud Fleurance, Helga Gerets, Stéphanie Glineur, Catrin Hasselgren, Andrea Kiessling, ...
Schedules – PHARMED
pharmed.helsci.be
Annick CAUVIN & Helga GERETS :00-17: Toxicology testing (Part II). Annie DELAUNOIS & Annick CAUVIN :00-17:00.
Evaluation of Impedance-Based Label-Free Technology ProQuestsearch.proquest.com › openview › 1.pdf
www.proquest.com
15 Mar · Franck André Atienzar *, Helga Gerets, Karen Tilmant, Gaëlle Toussaint and. Stéphane Dhalluin. UCB Pharma SA, Non Clinical Development, ...
[PDF] Discovery of a potent, orally bioavailable PI4KIIIβ DATAPDF.COMdatapdf.com › download
datapdf.com
29 Jun · and Helga Gerets for their help in formulation, safety profiling and establishing met ID. In memory of PLR. ABBREVIATIONS USED. ADME ...
sorted by relevance / date